RU2007121516A - Лечение мастита с помощью энрофлоксацина - Google Patents

Лечение мастита с помощью энрофлоксацина Download PDF

Info

Publication number
RU2007121516A
RU2007121516A RU2007121516/13A RU2007121516A RU2007121516A RU 2007121516 A RU2007121516 A RU 2007121516A RU 2007121516/13 A RU2007121516/13 A RU 2007121516/13A RU 2007121516 A RU2007121516 A RU 2007121516A RU 2007121516 A RU2007121516 A RU 2007121516A
Authority
RU
Russia
Prior art keywords
mastitis
treatment
enrofloxacin
obtain drugs
ciprofloxacin
Prior art date
Application number
RU2007121516/13A
Other languages
English (en)
Other versions
RU2413514C2 (ru
Inventor
Франц ПИРРО (DE)
Франц Пирро
Кристине ФРААТЦ (DE)
Кристине Фраатц
Робрехт ФРОЙМАН (DE)
Робрехт Фройман
Original Assignee
Байер ХельсКер АГ (DE)
Байер ХельсКер АГ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35462240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2007121516(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Байер ХельсКер АГ (DE), Байер ХельсКер АГ filed Critical Байер ХельсКер АГ (DE)
Publication of RU2007121516A publication Critical patent/RU2007121516A/ru
Application granted granted Critical
Publication of RU2413514C2 publication Critical patent/RU2413514C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

1. Применение энрофлоксацина для получения лекарственных средств для парентерального лечения маститов путем максимально двух введений.2. Способ лечения маститов, по которому пораженному животному парентерально вводят энрофлоксацин максимум дважды.3. Применение ципрофлоксацина для получения лекарственных средств для лечения мастита.

Claims (3)

1. Применение энрофлоксацина для получения лекарственных средств для парентерального лечения маститов путем максимально двух введений.
2. Способ лечения маститов, по которому пораженному животному парентерально вводят энрофлоксацин максимум дважды.
3. Применение ципрофлоксацина для получения лекарственных средств для лечения мастита.
RU2007121516/15A 2004-11-12 2005-10-28 Лечение мастита с помощью энрофлоксацина RU2413514C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004054873A DE102004054873A1 (de) 2004-11-12 2004-11-12 Behandlung von Mastitis
DE102004054873.0 2004-11-12

Publications (2)

Publication Number Publication Date
RU2007121516A true RU2007121516A (ru) 2008-12-20
RU2413514C2 RU2413514C2 (ru) 2011-03-10

Family

ID=35462240

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007121516/15A RU2413514C2 (ru) 2004-11-12 2005-10-28 Лечение мастита с помощью энрофлоксацина

Country Status (27)

Country Link
US (2) US20070265275A1 (ru)
EP (1) EP1812002B1 (ru)
JP (2) JP2008519781A (ru)
KR (1) KR20070084182A (ru)
CN (1) CN101056638A (ru)
AR (1) AR051763A1 (ru)
AT (1) ATE526970T1 (ru)
BR (1) BRPI0517473A (ru)
CA (1) CA2587187A1 (ru)
CR (1) CR9109A (ru)
DE (2) DE102004054873A1 (ru)
DK (1) DK1812002T3 (ru)
ES (1) ES2373449T3 (ru)
HR (1) HRP20120002T1 (ru)
IL (1) IL182993A (ru)
MX (1) MX2007005526A (ru)
NO (1) NO20072890L (ru)
NZ (1) NZ555062A (ru)
PE (1) PE20061139A1 (ru)
PL (1) PL1812002T3 (ru)
PT (1) PT1812002E (ru)
RU (1) RU2413514C2 (ru)
SI (1) SI1812002T1 (ru)
SV (1) SV2006002296A (ru)
UA (1) UA92593C2 (ru)
WO (1) WO2006050826A2 (ru)
ZA (1) ZA200703695B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5217276B2 (ja) * 2007-07-19 2013-06-19 ニプロ株式会社 注射用抗菌剤の製造方法
GB2480276A (en) * 2010-05-11 2011-11-16 Michael Hilary Burke Process for the preparation of an aqueous injectable enrofloxacin antimicrobial formulation
CN101933927A (zh) * 2010-06-30 2011-01-05 洛阳惠中兽药有限公司 一种含恩诺沙星六水合物组合物及其在制备治疗或预防家畜疾病的药物中的应用
RU2659430C2 (ru) * 2012-06-29 2018-07-02 Байер Энимл Хелс Гмбх Фармацевтические композиции и способ лечения маститов
EP2968231B1 (en) * 2013-03-15 2020-07-01 Boehringer Ingelheim Animal Health USA Inc. Antimicrobial polyamide compositions and mastitis treatment
RU2655772C1 (ru) * 2016-12-26 2018-05-29 Федеральное государственное бюджетное научное учреждение "Курский научно-исследовательский институт агропромышленного производства" Йодсодержащий состав для лечения мастита у коров
RU2652354C1 (ru) * 2017-11-07 2018-04-25 федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный аграрный университет" (ФГБОУ ВО Волгоградский ГАУ) Способ терапии коров, больных маститом
CN108051512A (zh) * 2017-11-27 2018-05-18 佛山科学技术学院 一种牛乳中氟喹诺酮类药物残留量的检测方法
CN110812326B (zh) * 2019-11-04 2022-04-22 黑龙江省农业科学院畜牧兽医分院 一种辛伐他汀混悬乳剂及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3333719A1 (de) 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
DE19500784A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
CA2176298C (en) 1995-06-27 2009-01-27 Dennis D. Copeland A single high dose fluoroquinolone treatment

Also Published As

Publication number Publication date
UA92593C2 (ru) 2010-11-25
IL182993A (en) 2013-03-24
CA2587187A1 (en) 2006-05-18
AR051763A1 (es) 2007-02-07
SV2006002296A (es) 2006-06-26
JP2008519781A (ja) 2008-06-12
ZA200703695B (en) 2008-08-27
US20130023540A1 (en) 2013-01-24
PE20061139A1 (es) 2006-12-29
EP1812002A2 (de) 2007-08-01
CR9109A (es) 2007-10-04
RU2413514C2 (ru) 2011-03-10
ES2373449T3 (es) 2012-02-03
BRPI0517473A (pt) 2008-10-07
NO20072890L (no) 2007-06-06
DK1812002T3 (da) 2012-02-06
PL1812002T3 (pl) 2012-03-30
DE102004054873A1 (de) 2006-05-18
NZ555062A (en) 2009-12-24
KR20070084182A (ko) 2007-08-24
DE202005022066U1 (de) 2012-12-06
CN101056638A (zh) 2007-10-17
ATE526970T1 (de) 2011-10-15
JP2013063985A (ja) 2013-04-11
EP1812002B1 (de) 2011-10-05
WO2006050826A3 (de) 2006-07-27
MX2007005526A (es) 2007-07-09
SI1812002T1 (sl) 2012-03-30
US20070265275A1 (en) 2007-11-15
PT1812002E (pt) 2011-12-30
WO2006050826A2 (de) 2006-05-18
IL182993A0 (en) 2007-09-20
HRP20120002T1 (hr) 2012-02-29

Similar Documents

Publication Publication Date Title
RU2007121516A (ru) Лечение мастита с помощью энрофлоксацина
DE602005023197D1 (de) -muscarinrezeptors
EA200801998A1 (ru) ПИРИДИН[3,4-b]ПИРАЗИНОНЫ
TW200738725A (en) Unsaturated mTOR inhibitors
DK2023918T3 (da) Cyclosporiner til behandlingen og forebyggelse af okulære lidelser
TW200801006A (en) Fused bicyclic mTOR inhibitors
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
IS8503A (is) Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar
NO20083630L (no) Nye pyridinderivater
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
DK1828177T3 (da) Hidtil ukendte MCH-receptorantagonister
TW200740776A (en) N-phenylbenzotriazolyl c-kit inhibitors
ATE414516T1 (de) Morphinanderivate als mittel gegen juckreiz
TW200519111A (en) N3-substituted imidazopyridine C-KIT inhibitors
GB0426313D0 (en) Therapeutic agents
EA201000039A1 (ru) Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль
RU2007122391A (ru) S-миртазапин для лечения приливов
DE602005011267D1 (de) Benzofuran- und benzothiophenderivate, die sich für die behandlung von herzkreislauferkrankungen eignen
TW200626140A (en) Preventing vertical endoparasite infections
TW200621223A (en) Acyclic 1,3-diamines and uses therefor
EA201001872A1 (ru) Новые способы получения производных циклопропиламида
BRPI0507811A (pt) derivados de 7h-pirrolopirimidina
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
CY1109803T1 (el) Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση
ITMI20040954A1 (it) Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20151029